Mitralix is a clinical stage medical technology company developed the Mistral - transcatheter repair device for Tricuspid and Mitral Valves Regurgitation.
Mitralix is dedicated to improve patients’ quality of life through its Mistral advanced technology that offers a unique solution for physicians and their patients suffering from tricuspid or mitral regurgitation.
Founder and CEO and Chairman of the Board of Mitralix Ltd.
An entrepreneur with over 30 years of experience in medical device industry with mechanical engineering background. The Founder and the inventor of Optonol Ltd., an Israeli company engaged with the development, manufacturing and commercializing miniature surgical implants. Its unique Ex-PRESS™ microscopic implant redefines the surgical treatment for patients with medically uncontrolled glaucoma. Under his management the company was acquired (2010) by Alcon Inc., the world leader in the field of eye care.
Co-Founder and GM of Mitralix Ltd.
A medical device industry executive with over 15 years of experience. Holds a degree in Biomedical Engineering(BSc), MBA from Technion technology institute and has co-founded medical device start up's in both cardiovascular and ophthalmic implants arena.
Led teams that have taken various products from concept through development and to clinical phase, including permanent implants.
Director and Chief Financial Officer for Mitralix Ltd.
Dan brings over 30 years of extensive experience of international financial background in the medical device industry in Israel, USA and Switzerland. Acted in senior management and financial capacities in Optonol Ltd., engaged with the development, manufacturing and commercializing miniature surgical implants, CardGuard / Lifewatch a leading developer, manufacturer and marketer of telemedicine diagnostic and monitoring systems, and other companies.